CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal) LABORATORY RESEARCH The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration Here, researchers identify palladin, an actin-associated protein, as an Akt1-specific substrate that modulates breast cancer cell invasive migration. [Mol Cell] Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies In this study, the researchers investigate the survival over time of women with six major subtypes of breast cancer classified using five immunohistochemical markers: the estrogen receptor and the progesterone receptor, the human epidermal growth factors receptor-2, and CK5/6 and epidermal growth factor receptor. [PLoS Med] Vascular Robo4 Restricts Proangiogenic VEGF Signaling in Breast Researchers identify a stromal, rather than epithelial, source of SLITs that inhibits blood vessel growth by signaling through endothelial ROBO4 to down-regulate VEGF/VEGFR2 signaling. [Proc Natl Acad Sci U S A] PTPL1/PTPN13 Regulates Breast Cancer Cell Aggressiveness through Direct Inactivation of Src Kinase By identification of protein tyrosine phosphatase 1 (PTPL1) as the first phosphatase able to inhibit Src through direct dephosphorylation in intact cells, researchers presently describe a new mechanism by which PTPL1 inhibits breast tumor aggressiveness. [Cancer Res] Tetraspanin CD151 Regulates Growth of Mammary Epithelial Cells in Three-Dimensional Extracellular Matrix: Implication for Mammary Ductal Carcinoma In situ Here, researchers examined the role of CD151 in proliferation of mammary epithelial cells using in vitro and in vivo models. [Cancer Res] Deregulated Estrogen Receptor Alpha and p53 Heterozygosity Collaborate in the Development of Mammary Hyperplasia Genetically engineered mouse models of deregulated ERalpha expression and p53 haploinsufficiency were used to investigate similarities and differences of each genetic lesion alone and in combination on mammary preneoplasia development. [Cancer Res] Therapeutic Efficacy of a DNA Vaccine Targeting the Endothelial Tip Cell Antigen Delta-Like Ligand 4 in Mammary Carcinoma Researchers have described a conceptually novel therapeutic strategy for targeting tumor angiogenesis and endothelial tip cells based on DNA vaccination against delta-like ligand 4. [Oncogene] Expression of Estrogen Receptor Alpha Increases Leptin-Induced STAT3 Activity in Breast Cancer Cells Here, researchers investigated cross-talk between estrogen receptor alpha and leptin-induced activation of signal transducer and activator of transcription 3 (STAT3), a transactivator of important oncogenes. [Int J Cancer] In Utero Exposure to Diethylstilbestrol (DES) or Bisphenol-A (BPA) Increases EZH2 Expression in the Mammary Gland: An Epigenetic Mechanism Linking Endocrine Disruptors to Breast Cancer Developmental programming of EZH2 is a novel mechanism by which in utero exposure to endocrine disruptors leads to epigenetic regulation of the mammary gland. [Hormones and Cancer] CLINICAL RESEARCH Phase III Multicenter Trial of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel Compared With Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel As Adjuvant Therapy for Women With High-Risk Breast Cancer This study compared disease-free survival obtained with two different regimens of adjuvant therapy in high-risk breast cancer. [ J Clin Oncol] Metastatic Behavior of Breast Cancer Subtypes Breast cancer subtypes are associated with distinct patterns of metastatic spread with notable differences in survival after relapse. [J Clin Oncol]
|
|
POLICY NEWS Cancer Center Marks Signing of Act on Screenings for Breast, Cervical and Colorectal Cancer The new measure gives statutory authority for breast, cervical and colorectal cancer screening programs to the Alabama Department of Public Health. [Alabama Department of Public Health, United States] NIH Wants More (Not Total) Disclosure of Financial Conflicts The federal government proposed an overhaul of regulations covering financial conflicts of interest in biomedical research. [National Institutes of Health, United States] NIH Requests Comments on the Proposed Rule Applicable to Regulations on the Responsibility of Applicants for Promoting Objectivity in Research for which Public Health Service Funding is Sought and Responsible Prospective Contractors (NOT-OD-10-099) [National Institutes of Health, United States] Notice of Format Clarification and Frequently Asked Questions (FAQs) for Funding Opportunity Announcement (FOA): RFA-HL-11-006, Next Generation Genetic Association Studies (U01) (NOT-HL-10-110) [National Institutes of Health, United States] Responsibility of Applicants for Promoting Objectivity in Research for Which Public Health Service Funding Is Sought and Responsible Prospective Contractors; Proposed Rule (Docket Number: NIH-2010-0001) [National Institutes of Health, United States] Charter of the Blood Products Advisory Committee (Update) [Food and Drug Administration, United States] FDA Transparency Initiative: Draft Proposals for Public Comment Regarding Disclosure Policies of the U.S. Food and Drug Administration; Availability [Docket No. FDA-2009-N-0247] [Food and Drug Administration, United States]
|
|
EVENTS American Society of Clinical Oncology (ASCO) Annual Meeting 2010 June 4-8, 2010 Chicago, United States Gordon Research Conference: Mammary Gland Biology June 6-11, 2010 Lucca (Barga), Italy 12th Milan Breast Cancer Conference June 16-18, 2010 Milan, Italy International Society for Stem Cell Research (ISSCR) 8th Annual Meeting June 16-19, 2010 San Francisco, United States The 21st Meeting of the European Association for Cancer Research (EACR) June 26-29, 2010 Oslo, Norway United Kingdom National Stem Cell Network (UKNSCN) Third Annual Scientific Conference July 12-14, 2010 Nottingham, United Kingdom Stem Cells USA & Regenerative Medicine Congress 2010 September 13-15, 2010 Philadelphia, United States 15th Congress of the European Society of Surgical Oncology (ESSO) September 15-17, 2010 Bordeaux, France 2010 World Cancer Congress August 18-21, 2010 Shenzhen, China 35th European Society for Medical Oncology (ESMO) Congress October 8-12, 2010 Milan, Italy International Symposium on Breast Cancer Prevention: Nutrition, Communications, Public Policy October 18-19, 2010 West Lafayette, United States 6th National Cancer Research Institute (NCRI) Conference November 7-10, 2010 Liverpool, United Kingdom JOB OPPORTUNITIES Senior Scientist – Magnetic Cell Separation (STEMCELL Technologies) Business Development Manager Europe – Cell Therapy Products (Pall Corporation) Sr. Product Support and Training Specialist (CardianBCT) Manager/Sr. Manager, Therapeutic Cell Solutions, Process Development (Lonza) Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News. Visit here to post your career opportunities. Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
Have we missed an important article or publication in Mammary Cell News? Click here to submit! |
| |
|